English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 5 October 2023, 08:52 HKT/SGT
Share:
    

Source: CorDx
CorDx to Launch New Global Brand, CuPet, in Singapore

SINGAPORE, Oct 5, 2023 - (ACN Newswire) - CorDx will take a revolutionary step in animal healthcare with the official global launch of CuPet at the 2023 Singapore Vet Show. CuPet aims to be customers' first choice in animal health, offering a one-stop solution for all diagnostic needs.

CuPet will showcase its innovative solutions at the Singapore Vet Show at booth D12 from October 13-14, 2023.

With an unwavering dedication to animal well-being, CuPet delivers accurate, intuitive, and affordable diagnostic test kits. Focused on efficiency and speed, CuPet diagnostic tests are designed for both veterinarians and pet owners. The brand prioritizes precise disease identification, ensuring quick and reliable results when every second counts. CuPet's comprehensive product range offers solutions for a variety of species and diseases, eliminating the need for multiple suppliers.

Developed through rigorous research, CuPet adheres to the highest scientific standards. The brand's product line includes 13 CE-marked test kits, employing advanced technologies such as colloidal gold and PCR. CuPet ensures user-friendly design, enabling both professionals and first-time pet owners to trust their intuitive solutions.

CuPet doesn't just provide products; it offers unparalleled customer support. From training to assistance, CuPet ensures that every user maximizes the utility and reliability of its products.

With a focus on affordability, CuPet challenges the market with competitive pricing without compromising on quality.

For More Information:

To view CuPet's product range or request a demo, visit en.cupet.com.

About CorDx :

Headquartered in the United States, CorDx is transforming the global diagnostics industry with innovative R&D solutions, a vertically integrated supply chain, and manufacturing footprints across the United States and around the world. Through its product realization partnerships with leading pharmaceutical companies, CorDx develops, manufactures, and distributes diagnostics and related tools that empower users to monitor and improve their health. Its proprietary line of diagnostics solutions is recognized by families and medical professionals for their reliability, affordability, and rapid results.

CorDx, a CorDx Union company, is a biotechnology organization that delivers medical device solutions to healthcare industries and over a billion users in more than 170 countries.

Contact Information

Jessica Wills, Marketing Director, cupet@cordx.com, (678) 6802380



Topic: Press release summary
Source: CorDx

Sectors: Regional
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
NEC Provides Vehicle Management Equipment for Autonomous Driving at Tokyo International Airport  
Monday, December 15, 2025 6:41:00 PM
NEC and AEROTHAI Elevate Air Traffic Safety with Advanced Time Sync Solutions from Adtran Oscilloquartz  
Monday, December 15, 2025 6:04:00 PM
Everest Medicines Unveils 2030 Strategy as Directors and Substantial Shareholder Buy Over HKD 38 Million of Shares  
Dec 15, 2025 16:59 HKT/SGT
Indonesia's KAI Launches Farmer-Trader Train, Expands Facial Recognition Tech Ahead of 2025/2026 Holiday Travel Surge  
Dec 15, 2025 13:00 HKT/SGT
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations  
Dec 15, 2025 09:51 HKT/SGT
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership  
Monday, December 15, 2025 7:30:00 AM
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion  
Friday, December 12, 2025 10:15:00 PM
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten  
Dec 12, 2025 14:35 HKT/SGT
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition  
Friday, December 12, 2025 10:00:00 AM
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China  
Dec 11, 2025 20:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575